ICH Considerations: general principles to address the risk of inadvertent germline integration of gene therapy vectors

  • Email
  • Help
Current version

ICH Considerations

Reference numberCHMP/ICH/469991/2006
Published01/11/2006
KeywordsGene therapy vectors, non-clinical, clinical, biosafety, oncolytic viruses
DescriptionThis document identifies general principles for investigating and addressing risks for inadvertent germline integration. It provides considerations to minimise this potential risk in humans enrolled in clinical trials. This document applies to gene therapy vectors and could also apply to oncolytic viruses.

How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more